Pharmaceutical Substances Syntheses, Patents, Applications - Part 49

Pharmaceutical Substances Syntheses, Patents, Applications - Part 49. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Ciprofibrate C 481 Br2 OVCH3 2 0 I ------------- bromine OH 3-bromo-4-hydroxy- 6 7-methylenedioxy-cinnoline CuCN DMF ----------------- copper l cyanide OH 3-cyono-4-hydroxy- 6 7-methylenedioxy-cinnoline n n HjC i 1. NaH DMF 2. HCI CHjCOOH ethyl iodide Referenced US 3 669 965 Eli Lilly prior. . DOS 2 005 104 Eli Lilly appl. . Formulation s cps. 250 mg 500 mg Trade Name s D Cinoxacin Rosen Pharma GB Cinobac Lilly 1979 I Cinobac Lilly Nossacin Corvi Noxigram Firma Uronorm Alfa Wassermann Uroxacin Malesci J Cinobact Shionogi USA Cinobac Dista 1981 wfm Ciprofibrate atc bo4Ac coiabos Use antihyperlipidemic clofibrate derivative RN 52214-84-3 MF CI3H14C12O3 MW EINECS 257-744-6 CN 2- 4- 2 2-dichlorocyclopropyl phenoxy -2-methylpropanoic acid styrene 1 1 -dichloro-2-phenylcyclopropone 1. HNOj. H2S04 2. H2O 3. H2 Raney-Ni 4- 2 2 - dichlorocyclo-propyl oniline U 1. NaN02 CHjCOOH 2. H2SO4 n-------------------- 4- 2 2-dichlorocyclo-propyl phenol u h3c ch3 . I . NaOH --------k Ciprofibrote 482 C Ciprofloxacin Reference s US 3 948 973 Sterling Drug prior. . DOS 2 343 606 Sterling Drug appl. USA-prior. . synthesis o 4- 2 2-dichlorocyclopropyl aniline Nefedov . Shafran . Zh. Org. Khim. ZORKAE 1974 477. . CHABA8 80 145626o 1974 . Formulation s cps. 100 mg tabl. 100 mg Trade Name s F Lipanor Sanofi Winthrop GB Modalim Sanofi Winthrop 1985 Ciprofloxacin Bay-o-9867 ATC J01MA02 S03AA07 Use antibacterial RN 85721-33-1 MF C17H18FN3O3 MW LD50 122 mg kg M . 5 g kg M . 207 mg kg R . 2 g kg R . CN l-cyclopropyl-6-fluoro-l 4-dihydro-4-oxo-7- l-piperazinyl -3-quinolinecarboxylic acid monohydrate RN 113078-43-6 MF C17H18FN3O3 H2O MW monohydrochloride RN 93107-08-5 MF C17H18FN3O3 HC1 MW . hydrochloride RN 86483-48-9 MF C17H18FN3O3 xHCl MW unspecified LD5 I 258 mg kg M . 5 g kg M . 300 mg kg R . 5 g kg R . lactate 1 1 RN 97867-33-9 MF C17H18FN3O3 C3H O3 MW 0 1 CI

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
24    19    1    27-11-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.